ロード中...
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
BACKGROUND: Nephrotic syndrome is a disorder characterized by proteinuria, hypoalbuminemia and dyslipidemia. Low-dose alternate-day steroid regimen is the standard of care. In case of relapse or significant adverse events, steroid-sparing agents may be used. This analysis was aimed at assessing the...
保存先:
| 出版年: | Ital J Pediatr |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4943005/ https://ncbi.nlm.nih.gov/pubmed/27405390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-016-0271-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|